BCIQ Profiles

Company Profile Report

AI tools against COVID-19: a view from where the rubber hits the road

A conversation on bias, speed and accuracy in AI approaches against COVID-19

Making machine learning an effective tool in the fight against COVID-19 requires broad access to data, scrupulous checks for bias, and strategies to balance speed and accuracy, according to researchers with AI-based diagnostics and literature-mining programs in a webinar co-sponsored by BioCentury and Life Sciences Washington.

Adaptive Biotechnologies Corp. (NASDAQ:ADPT) CEO and co-founder Chad Robins said the company’s work to rapidly characterize T cell

Read the full 637 word article

How to gain access

Continue reading with a
two-week free trial.